FirmaIQ
Org.nr 981 363 019 2019 → 2020 Year-over-year analysis

ABBOTT DIAGNOSTICS TECHNOLOGIES AS: årsregnskap 2020 vs 2019

Shrank 10% on revenue, weaker earnings

approved 2021-08-27; registry 2021-10-13; journal 2021 808891

Full company analysis · All year comparisons

Summary

What changed

Comparing Årsregnskap 2020 with 2019 for ABBOTT DIAGNOSTICS TECHNOLOGIES AS. Revenue 975.82m NOK → 876.85m NOK (-10.1%). Net result +212.65m NOK → +132.21m NOK. Equity 999.81m NOK → 956.60m NOK.

On the constructive side: cash rose. Pressures included: revenue fell; operating result weakened; net result weakened.

Also worth watching: cogs fell; book investments changed. All figures are taken from the published annual accounts for ABBOTT DIAGNOSTICS TECHNOLOGIES AS.

At a glance

Scorecard

Revenue
975.82m NOK 876.85m NOK
-10.1%
Operating result
+270.13m NOK +164.12m NOK
-39.2%
Net result
+212.65m NOK +132.21m NOK
-37.8%
Equity
999.81m NOK 956.60m NOK
-4.3%
Cash
7.30m NOK 8.46m NOK
+15.9%
Total assets
1.25bn NOK 1.35bn NOK
+8.1%

What improved

  • ↑

    Cash rose

    Bank deposits 7.30m NOK → 8.46m NOK (+15.9% YoY). Calculated

What deteriorated

  • ↓

    Revenue fell

    Operating income / revenue moved from 975.82m NOK to 876.85m NOK (-10.1% YoY). Calculated

  • ↓

    Operating result weakened

    Operating result +270.13m NOK → +164.12m NOK (op. margin 27.7% → 18.7%). Calculated

  • ↓

    Net result weakened

    Net result +212.65m NOK → +132.21m NOK (net margin 21.8% → 15.1%). Calculated

  • ↓

    Equity eroded

    Book equity 999.81m NOK → 956.60m NOK (equity ratio 80.1% → 70.9%). Calculated

  • ↓

    Current ratio dropped below 1×

    Current ratio 1.61× → 0.66× — short-term liabilities now exceed liquid/current assets on the published lines. Calculated

Things to notice

  • ·

    COGS fell

    COGS / varekostnad 349.94m NOK → 308.42m NOK (-11.9% YoY). Calculated

  • ·

    Book investments changed

    Investment / intangible book value 764.31m NOK → 876.74m NOK. Reported fact